Bisacodyl Market Comprehensive Insight by Growth Rate, Industry Status, Forecast till 2027

The global bisacodyl market is anticipated to grow at a significant CAGR during the forecast period (2021-2027). Bisacodyl is an organic compound that is used as a stimulant laxative drug and is prescribed for the relief of constipation and the management of neurogenic bowel dysfunction. It is also used as part of bowel preparation before medical examinations, such as for a colonoscopy. The major factor for the growth of the market during the forecast period is the rising prevalence of constipation related diseases.

According to the National Center for Biotechnology Information (NCBI), more than 4 million people in the US have frequent constipation which corresponded to a prevalence of about 2%. Additionally, as per the same source, constipation is the most common digestive complaint in the US. Furthermore, constipation is also caused due to the treatment of cancer. Hence, the rising prevalence of cancer is further driving the growth of the global bisacodyl market.

To Request a Sample of our Report on Bisacodyl Market:  https://www.omrglobal.com/request-sample/bisacodyl-market

Some major key players in the market include GlaxoSmithKline plc, Sanofi S.A., and Cipla Ltd., among others. The market players are contributing significantly to the growth of the market by the adoption of various strategies including mergers & acquisitions, geographical expansion, partnerships and collaborations, and new product launches, to stay competitive in the market. For instance, in December 2021, Shilpa Medicare launched PRUCALSHIL (Prucalopride), orally disintegrating strips of 1 mg and 2 mg in India for the treatment of chronic constipation. 

Market Coverage

    • The market number available for – 2020-2027

    • Base year- 2020

    • Forecast period- 2021-2027

    • Segment Covered– 

·                  By Type

·                  By Application

•             Regions Covered-

·                  North America

·                  Europe

·                  Asia-Pacific

·                  Rest of the World

•       Competitive Landscape- GlaxoSmithKline plc, Sanofi S.A., and Cipla Ltd., among others.

(Get 15% Discount on Buying this Report)

A full Report of Bisacodyl Market is Available at:  https://www.omrglobal.com/industry-reports/bisacodyl-market

Global Bisacodyl Market Report by Segment

By Type 

    • Low Purity

    • High Purity

By Application 

    • Constipation

    • Neurogenic Bowel Dysfunction

    • Others

Global Bisacodyl Market Report by Region

North America

·        United States

·        Canada

Europe

·        UK

·        Germany

·        Spain

·        France

·        Italy

·        Rest of Europe

Asia-Pacific

·                  India

·                  China

·                  Japan

·                  South Korea

·                  Rest of APAC

Rest of the World

·        Latin America 

·        Middle East & Africa

Reasons to buy from us –

1.  We cover more than 15 major industries, further segmented into more than 90 sectors.

2.  More than 120 countries are for analysis.

3.  Over 100+ paid data sources mined for investigation.

4.  Our expert research analysts answer all your questions before and after purchasing your report.

About Orion Market Research 

Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

Media Contact:

Company Name: Orion Market Research

Contact Person: Mr. Anurag Tiwari

Email: info@omrglobal.com

Contact no:  +91 7803040404

Leave a Reply

Your email address will not be published. Required fields are marked *